Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions

Attention Deficit Disorder With HyperactivityConduct DisorderSubstance Abuse

Interventions

DRUG

Adderall

3 weeks of Adderall

Trial Locations (1)

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Jeffrey Newcorn

OTHER

NCT04170738 - Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder | Biotech Hunter | Biotech Hunter